Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from Pramipexole IR to ER in Early Parkinson's Disease
NCT00558025Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of pramipexole in Parkinson's disease (PD), sponsored by Boehringer Ingelheim. Started Oct 2007; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00558025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558025.